Go Pro
→ 'How Much Can I Actually Spend Each Year With $2.5M Saved?' (From SmartAsset) (Ad)tc pixel
OTCMKTS:EKTAY

Elekta Q4 2025 Earnings Report

Elekta logo
$5.09 0.00 (0.00%)
As of 09/25/2026 01:10 PM Eastern
ProfileEarnings HistoryForecast

Elekta EPS Results

Actual EPS
$0.11
Consensus EPS
$0.13
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Elekta Revenue Results

Actual Revenue
$503.22 million
Expected Revenue
$507.19 million
Beat/Miss
Missed by -$3.97 million
YoY Revenue Growth
N/A

Elekta Announcement Details

Quarter
Q4 2025
Date
5/28/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Elekta's next earnings date is estimated for Wednesday, November 25, 2026, based on past reporting schedules.

Conference Call Resources

Elekta Earnings Headlines

Elekta Broadens Adaptive Radiotherapy Portfolio Across Modalities
September 27 at 12:11 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-broadens-adaptive-radiotherapy-portfolio-across-modalities?utm_source=marketbeat.com&utm_medium=referral
Insulet (NASDAQ:PODD) & Elekta (OTCMKTS:EKTAY) Critical Comparison
September 27 at 8:14 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31055432
"How Much Can I Actually Spend Each Year With $2.5M Saved?"
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you make with it. Using the 4% rule as a benchmark, that balance could translate to about $100,000 in year one, adjusted upward for inflation each year after. But the 4% rule has potential downsides and may not fit every portfolio. A financial advisor can help size and structure a retirement budget around your income sources, taxes, and goals. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors.tc pixel
 |  SmartAsset (Ad)
Elekta AGM Approves Dividend, Board Mandates and New Incentive Plan
September 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-agm-approves-dividend-board-mandates-and-new-incentive-plan?utm_source=marketbeat.com&utm_medium=referral
Elekta AB earnings call: margins up, growth uneven
August 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-ab-earnings-call-margins-up-growth-uneven?utm_source=marketbeat.com&utm_medium=referral
Elekta AB (publ) (EKTAY) Q1 2027 Earnings Call Transcript
August 27, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4940741-elekta-ab-publ-ektay-q1-2027-earnings-call-transcript
See More Elekta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email.

About Elekta

Elekta (OTCMKTS:EKTAY) is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software. Elekta also provides related services, support and upgrades for healthcare providers.

Founded in 1972 by neurosurgeon Lars Leksell, Elekta has grown into an international supplier serving hospitals, clinics and cancer centers across Europe, North and South America, Asia-Pacific, the Middle East and Africa. The company is headquartered in Stockholm, Sweden, and its shares trade on Nasdaq Stockholm under the symbol “EKTA”; its American depositary shares trade over the counter under the symbol “EKTAY.”

View Elekta Profile
Earnings Tools